I don't disagree with what you've written. My point, however, is that were the unprecedented 5 week results sustained over 31 weeks, the update would be a sensation that would have conference organizers DEMANDING an oral presentation. I don't think it was an accident that the 12 week data was never presented, and I predict the present update will show a more muted response to the drug than previously reported.